Litcius/Paper detail

The novel DYRK1A inhibitor KVN93 regulates cognitive function, amyloid-beta pathology, and neuroinflammation

Hyunju Lee, Hanwoong Woo, Ha-Eun Lee, Hyongjun Jeon, Ka‐Young Ryu, Jin Han Nam, Seong Gak Jeon, HyunHee Park, Ji-Soo Lee, Kyung‐Min Han, Sang Min Lee, Jeongyeon Kim, Jeongyeon Kim, Ri Jin Kang, Young‐Ho Lee, Jae‐Ick Kim, Jae‐Ick Kim, Hyang‐Sook Hoe

2020Free Radical Biology and Medicine34 citationsDOI

Topics & Concepts

NeuroinflammationDYRK1AAstrocyteAmyloid betaNeprilysinMicrogliaChemistryPharmacologyKinaseNeuroscienceMedicineBiologyInternal medicineInflammationCentral nervous systemEnzymeBiochemistryDiseaseAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsTryptophan and brain disorders
The novel DYRK1A inhibitor KVN93 regulates cognitive function, amyloid-beta pathology, and neuroinflammation | Litcius